Findcure Biosciences (zhongshan) Co., Ltd.

This is a very early study to find the safest dose of a new drug called 177Lu-INN805 for people with advanced solid tumors that haven't responded to standard treatments. It will enroll about 10 patients with cancers like head & neck, lung, breast, or sarcoma to test how the body …

This early-stage study is testing a new radioactive tracer called ⁶⁸Ga-FC516 for use in PET/CT scans. The goal is to see if this new agent is safe, where it goes in the body, and if it can help doctors spot prostate cancer tumors as well as or better than existing imaging methods…